Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | HemaSphere |
Online Access: | https://doi.org/10.1002/hem3.37 |
_version_ | 1797321285379817472 |
---|---|
author | Roger E. G. Schutgens |
author_facet | Roger E. G. Schutgens |
author_sort | Roger E. G. Schutgens |
collection | DOAJ |
first_indexed | 2024-03-08T04:56:19Z |
format | Article |
id | doaj.art-3b6b154e008440ba8eab5c546c31e881 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-08T04:56:19Z |
publishDate | 2024-01-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-3b6b154e008440ba8eab5c546c31e8812024-02-07T15:15:48ZengWileyHemaSphere2572-92412024-01-0181n/an/a10.1002/hem3.37Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodiesRoger E. G. Schutgens0Center of Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Centre Utrecht University Utrecht Utrecht The Netherlandshttps://doi.org/10.1002/hem3.37 |
spellingShingle | Roger E. G. Schutgens Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies HemaSphere |
title | Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies |
title_full | Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies |
title_fullStr | Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies |
title_full_unstemmed | Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies |
title_short | Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies |
title_sort | imlifidase for hematologists creating a therapeutic window in the presence of neutralizing alloantibodies |
url | https://doi.org/10.1002/hem3.37 |
work_keys_str_mv | AT rogeregschutgens imlifidaseforhematologistscreatingatherapeuticwindowinthepresenceofneutralizingalloantibodies |